We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 5,678 results
  1. A new childhood ALL case with an extremely complex karyotype and acute spontaneous tumor lysis syndrome

    Background

    B cell precursor acute lymphoblastic leukemia (B-ALL) is the most common malignancy of childhood, with, after corresponding treatment, an...

    Abdulsamad Wafa, Rami A. Jarjour, ... Walid Al-Achkar in Molecular Cytogenetics
    Article Open access 11 September 2020
  2. Tumor Immunology and Immunotherapy

    Understanding immune mechanisms in cancer and immunotherapy has made cancer diagnosis and treatment more effective. The immune system can recognize...
    Thi Kim Anh Nguyen, Huu-Thinh Nguyen, Sao-Mai Dam in Cancer Treatment: An Interdisciplinary Approach
    Chapter 2023
  3. Bortezomib administration is a risk factor associated with the development of tumor lysis syndrome in male patients with multiple myeloma: a retrospective study

    Background

    Novel agents such as proteasome inhibitors have been developed for several years to treat multiple myeloma. Although multiple myeloma is a...

    Masahiro Kondo, Yuji Hotta, ... Kazunori Kimura in BMC Cancer
    Article Open access 17 November 2020
  4. Tumor-on-a-Chip: Microfluidic Models of Hypoxic Tumor Microenvironment

    Cancer is ranked as the deadliest prime health issue, albeit with mammoth efforts to panacea the ailment. To subdue the vast constraints in tumor...
    Arpana Parihar, Nishant Kumar Choudhary, ... Raju Khan in Hypoxia in Cancer: Significance and Impact on Cancer Therapy
    Chapter 2023
  5. Tumor Lysis Syndrome

    Tumor lysis syndrome refers to the laboratory and clinical results of rapid breakdown of high volumes of malignant cells. Significant electrolyte...
    Gareth P. Gregory, Jake Shortt in Textbook of Palliative Care
    Reference work entry 2019
  6. Mouse Models of Obesity to Study the Tumor-Immune Microenvironment

    Obesity is associated with chronic, low-grade systemic inflammation and leads to changes in the immune microenvironment of various tissues. As a...
    Sarah Petrecca, Daniela F. Quail in The Tumor Microenvironment
    Protocol 2023
  7. The golden key to open mystery boxes of SMARCA4-deficient undifferentiated thoracic tumor: focusing immunotherapy, tumor microenvironment and epigenetic regulation

    SMARCA4-deficient undifferentiated thoracic tumor is extremely invasive. This tumor with poor prognosis is easily confused with SMARCA4-deficent...

    **ang Li, Sen Tian, ... Chong Bai in Cancer Gene Therapy
    Article Open access 13 February 2024
  8. PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models

    Background

    T cell receptor fusion constructs (TRuC) consist of an antibody-based single chain variable fragment (scFv) fused to a T cell receptor...

    Stefanie Lesch, Alessia Nottebrock, ... Sebastian Kobold in Cellular Oncology
    Article Open access 21 November 2022
  9. A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity

    Background

    Osteosarcoma (OS) is one of most commonly diagnosed bone cancer. Circular RNAs (circRNAs) are a class of highly stable non-coding RNA, the...

    Ying Zhang, Zhaoyong Liu, ... Chuangzhen Chen in Journal of Experimental & Clinical Cancer Research
    Article Open access 21 February 2024
  10. The crosstalk between immune cells and tumor pyroptosis: advancing cancer immunotherapy strategies

    Pyroptosis is a cell death process characterized by cell swelling until membrane rupture and release of intracellular contents. As an effective tumor...

    Mengyuan Hu, Fengying Deng, ... Fei Yan in Journal of Experimental & Clinical Cancer Research
    Article Open access 10 July 2024
  11. The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications

    DNA methylation is a pivotal epigenetic modification that affects gene expression. Tumor immune microenvironment (TIME) comprises diverse immune...

    Daoqi Zhu, Siying Zeng, ... Qin Fan in Clinical Epigenetics
    Article Open access 08 February 2024
  12. Application of the PGT-M strategy using single sperm and/or affected embryos as probands for linkage analysis in males with hereditary tumor syndromes without family history

    Hereditary tumor syndromes have garnered substantial attention due to their adverse effects on both the physical and psychological health of...

    ** Chen, Yuqian Wang, ... Jie Qiao in Journal of Human Genetics
    Article 18 August 2023
  13. The opposing effect of acute and chronic Toxoplasma gondii infection on tumor development

    Background

    The interplay between Toxoplasma gondii infection and tumor development is intriguing and not yet fully understood. Some studies showed...

    Yining Song, Hao Yuan, ... Zi-Guo Yuan in Parasites & Vectors
    Article Open access 04 June 2024
  14. The Role of Tumor Microenvironment in Colon Cancer

    Colorectal cancer (CRC) is one of the most common causes of morbidity and mortality in both women and men. Given that CRC is an important health...
    Caterina Fattorini, Marco Arganini, ... Maria Raffaella Ambrosio in Gastrointestinal Cancers: An Interdisciplinary Approach
    Chapter 2022
  15. Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy

    Natural killer (NK) cells are unique from other immune cells in that they can rapidly kill multiple neighboring cells without the need for antigenic...

    Linxuan Miao, Chenglin Lu, ... **aonan Cui in Journal of Translational Medicine
    Article Open access 03 March 2024
  16. Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer

    Background

    Chimeric antigen receptor (CAR) -T cell therapy is an efficient therapeutic strategy for specific hematologic malignancies. However,...

    Jian Chen, Tianchuan Zhu, ... ** Huang in Molecular Cancer
    Article Open access 10 August 2023
  17. Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment

    Gangliosides are sialylated glycolipids, mainly present at the cell surface membrane, involved in a variety of cellular signaling events. During...

    Irene van der Haar Àvila, Britt Windhouwer, Sandra J. van Vliet in Cancer and Metastasis Reviews
    Article Open access 02 June 2023
  18. Advances in tumor nanotechnology: theragnostic implications in tumors via targeting regulated cell death

    Cell death constitutes an indispensable part of the organismal balance in the human body. Generally, cell death includes regulated cell death (RCD)...

    ** Li, **anyanling Yi, ... Jianzhong Ai in Apoptosis
    Article 15 May 2023
  19. miR-29a-SIRT1-Wnt/β-Catenin Axis Regulates Tumor Progression and Survival in Hepatocellular Carcinoma

    Sirtuin 1 (SIRT1) participates in the initiation and evolution of hepatocellular carcinoma (HCC). However, the specific mechanism of SIRT1 in HCC...

    Liqiang Qian, Yanjun Zhang, ... Lei Qin in Biochemical Genetics
    Article 30 September 2023
  20. Role of myeloid-derived suppressor cells in tumor recurrence

    The establishment of primary tumor cells in distant organs, termed metastasis, is the principal cause of cancer mortality and is a crucial...

    Kathryn Cole, Zaid Al-Kadhimi, James E. Talmadge in Cancer and Metastasis Reviews
    Article 14 January 2023
Did you find what you were looking for? Share feedback.